1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Orthopedics Market Trends
  5. > China Orthopedic Instrument Industry Report, 2014-2017

China Orthopedic Instrument Industry Report, 2014-2017

  • August 2014
  • -
  • Research In China
  • -
  • 104 pages

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.

Being optimistic about bright future of China orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China’s largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014.

The Chinese orthopedic instrument market now is dominated by Johnson & Johnson, Zimmer, Medtronic, Stryker and other foreign companies, together holding 40%-50% market share. However, local Chinese companies like Shandong Weigao Group Medical Polymer Co. Limited, Shanghai Kinetic Medical Co., Ltd. and United Orthopedic Corporation have made some progress in R&D and production technology in recent years, and grabbed some marker share by virtue of advantages in cost and channel.

Shandong Weigao Group Medical Polymer has become the largest local orthopedics company in China with a market share of 4.3%; Shanghai Kinetic Medical is a leader in vertebroplasty interventional operation system, occupying about 50% of the Chinese percutaneous kyphoplasty (PKP) market; United Orthopedic Corporation is a champion in artificial knee/hip joint with 4%-6% market share in China.

China Orthopedic Instrument Industry Report, 2014-2017 focuses on the following:
Development of the Chinese orthopedic instrument market, including market size, market structure, import & export, competitive landscape, barriers to entry and sales model;
Development environment of the Chinese orthopedic instrument market, covering global market environment, policy environment, macro environment, upstream and downstream sectors and development prospects;
Operation and orthopedic instrument business of 4 foreign and 14 local Chinese orthopedics companies.

Table Of Contents

China Orthopedic Instrument Industry Report, 2014-2017
1. Overview of Orthopedic Instrument Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development of Global Orthopedic Instrument Industry
2.1 Overview
2.2 Forecast

3. Development of China Orthopedic Instrument Industry
3.1 Overview
3.2 Market Structure
3.3 Import and Export
3.3.1 Import
3.3.2 Export
3.4 Competitive Landscape
3.5 Barriers to Entry
3.5.1 Technology Barrier
3.5.2 Market Access Barrier
3.5.3 Sales Channel Barrier
3.5.4 Talent Barrier
3.6 Sales Model

4. Development Environment of China Orthopedic Instrument Industry
4.1 Policy Environment
4.1.1 Regulatory Policy
4.1.2 Industrial Policy
4.2 Macro Environment
4.3 Upstream and Downstream Industries
4.3.1 Upstream Industry
4.3.2 Downstream Industry
4.4 Prospects

5. Foreign Companies in China
5.1 Johnson and Johnson
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Orthopedic Instrument Business
5.1.6 Development in China
5.2 Medtronic
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 Orthopedic Instrument Business
5.2.6 Development in China
5.3 Stryker
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 Development in China
5.4 Zimmer
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Orthopedic Instrument Business
5.4.6 Development in China

6. Major Chinese Companies
6.1 Shandong Weigao Group Medical Polymer
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 Orthopedic Instrument Business
6.1.6 RandD and Investment
6.1.7 Customers
6.1.8 Forecast and Outlook
6.2 Shanghai Kinetic Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 RandD and Investment
6.2.6 Forecast and Outlook
6.3 United Orthopedic Corporation
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 RandD and Investment
6.3.6 Forecast and Outlook
6.4 Beijing AKEC Medical
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 RandD and Investment
6.4.6 Capacity, Output and Sales Volume
6.4.7 Customers and Suppliers
6.5 Suzou Xinrong Best Medical Instrument
6.5.1 Profile
6.5.2 Operation
6.5.3 Orthopedic Instrument Business
6.6 Tianjin Walkman Biomaterial
6.6.1 Profile
6.6.2 Operation
6.6.3 Orthopedic Instrument Business
6.7 Beijing Lidakang Science and Technology
6.7.1 Profile
6.7.2 Operation
6.7.3 Orthopedic Instrument Business
6.8 Tianjin Renli Orthopedic Instrument
6.8.1 Profile
6.8.2 Operation
6.9 Zhejiang Guangci Medical Device
6.9.1 Profile
6.9.2 Orthopedic Instrument Business
6.10 Suzhou AND Science and Technology Development
6.10.1 Profile
6.10.2 Orthopedic Instrument Business
6.11 Beijing Chunlizhengda Technology and Development
6.11.1 Profile
6.11.2 Orthopedic Instrument Business
6.12 Baimtec Material
6.12.1 Profile
6.12.2 Orthopedic Instrument Business
6.13 Suzhou Kangli Orthopedics Instrument
6.13.1 Profile
6.13.2 Orthopedic Instrument Business
6.14 Waston Medical Appliance
6.14.1 Profile
6.14.2 Orthopedic Instrument Business

7. Forecast and Outlook
7.1 Market Size Forecast
7.2 Operation Comparison of Major Companies
7.2.1 Revenue
7.2.2 Net Income
7.2.3 Gross Margin
7.2.4 Orthopedic Instrument Business

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Hip Replacement Implant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hip Replacement Implant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • February 2017
  • by Transparency Market Research

Global Hip Replacement Implant Market: Overview Hip Replacement Implant are the artificial implant made of metal, plastics or ceramic which are replaced with the hip joint. Hip replacement procedure takes ...

Bone Morphogenetic Protein Market Analysis By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial Surgery), By Region And Segment Forecasts, 2013 - 2024

Bone Morphogenetic Protein Market Analysis By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial Surgery), By Region And Segment Forecasts, 2013 - 2024

  • $ 4950
  • Industry report
  • December 2016
  • by Grand View Research

The global bone morphogenetic protein (BMP) market size is expected to reach over USD 644.6 million by 2024, based on a new report by Grand View Research, Inc. Increasing incidence of spinal fusion, trauma, ...

Orthobiologics Market Analysis By Product (DBM, Allograft, BMP, Viscosupplementation, Synthetic Bone Substitutes, Stem Cell), By Application (Spinal Fusion, Reconstructive Surgery, Trauma Repair), By End Use And Segment Forecasts, 2014 - 2025

Orthobiologics Market Analysis By Product (DBM, Allograft, BMP, Viscosupplementation, Synthetic Bone Substitutes, Stem Cell), By Application (Spinal Fusion, Reconstructive Surgery, Trauma Repair), By End Use And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The global orthobiologics market is expected to reach USD 10.2 billion by 2025, according to a new study by Grand View Research, Inc. The orthobiologics market is predominantly driven by the increasing ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.